Comparing two doses of cetirizine for sudden hives
Treatments studied
Part of Skin clinical trials.
This trial tests whether a higher dose of cetirizine (an allergy medicine) works better than the standard dose for treating sudden hives in adults. It may help people who have had new hives in the last day and are not taking certain other medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- A doctor has diagnosed you with sudden hives (acute urticaria)
- Your hives started within the last 24 hours
- You are able to fill out symptom diaries and attend follow-up visits
- You are not pregnant or breastfeeding
- You have not used certain medicines like steroids, immunosuppressants, ACE inhibitors, or ARBs in the past 5 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injectable medication (cetirizine, a type of antihistamine) to see if it quickly relieves itching and hives in adults with acute (short-term) hives. It is for people whose hives have lasted less than 6 weeks and who still have bothersome symptoms.
This study compares different treatment options for people with chronic hives (urticaria) that last longer than 6 weeks. It aims to find which treatment works best to reduce itching and welts.
This trial tests an experimental medicine for chronic hives (called chronic spontaneous urticaria). It is for people whose hives still bother them about once or twice a month despite daily treatment, and who do not have heart problems.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This study tests an investigational pill called THB335 for adults whose hives (itchy welts) keep appearing despite taking antihistamines. The goal is to see if this treatment can reduce itching and hives and improve quality of life.
This trial tests a new medicine, JYB1904, for people with chronic hives (itching and welts) that haven't been controlled by standard allergy pills. It aims to see if JYB1904 can reduce itching and hives better.
Hear when a new Acute Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.